Those are both important points. I will make one comment about the second one. The spreading of best practice is central. We must ensure that we do not just have a system where we have new NICE guidelines, but that we have confidence that it is being implemented across 30,000 GPs in 250 NHS trusts and so on, and I know Baroness Cumberlege will be thinking about that.
Medicines and Medical Devices Safety Review
Proceeding contribution from
Jeremy Hunt
(Conservative)
in the House of Commons on Wednesday, 21 February 2018.
It occurred during Ministerial statement on Medicines and Medical Devices Safety Review.
Type
Proceeding contribution
Reference
636 c177
Session
2017-19
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2020-07-09 15:43:11 +0100
URI
http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000015
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000015
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2018-02-21/18022160000015